ArticlePloS one2024
Evaluating the risk of sleep disorders in subjects with a prior COVID-19 infection.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- COVID-19 and risk of self-harm, suicidal ideation, and poisoning in children and adolescents.Annals of medicine · 2025Article
- Unraveling the Effects ofInternational journal of molecular sciences · 2025Review
- Incidence of depression and anxiety in children and adolescents following COVID-19 infection.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Previous studies have reported a potential occurrence of sleep disorders in patients following a COVID-19 infection. However, these findings were based on surveys or retrospective studies with small sample sizes. This study examined if subjects with a previous COVID-19 infection in 2020 experienced sleep disorders in 2021. Using the 2019-2021 Utah All Payers Claims Database (APCD), adults (≥18 to 62 years old in 2019) covered by private insurance and Medicaid were identified. Sleep disorders were identified from the primary and secondary diagnosis in 2021. Baseline characteristics of subjects such as age, gender, race/ethnicity, type of insurance, and comorbid conditions were identified from the database. Entropy balancing was used to balance the baseline characteristics of subjects with and without a COVID-19 infection in 2020. Weighted logistic regression was used to identify significant factors that were associated with sleep disorders. A total of 413,958 subjects were included in the study. The average (SD) age was 38 (17) years old in 2019 and 58% were female. Among the subjects, about 39% had a COVID-19 infection in 2020. Those who had a COVID-19 infection in 2020 were 53% more likely to have a sleep disorder in 2021 (OR = 1.53; 95% Confidence Interval: 1.48-1.58). Sleep disorders could be one of long-term COVID-19 symptoms. More screening and observations for those who had a COVID-19 infection could be important to improve sleep related problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.